Description
Ipamorelin Technical Overview
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. It has been investigated for its interaction with the growth hormone secretagogue receptor (GHS-R1a).
GHS-R1a is also activated by the endogenous peptide hormone ghrelin and participates in endocrine signaling pathways associated with growth hormone secretion.
Experimental research has examined Ipamorelin receptor pharmacology, growth hormone responses, and its selectivity relative to other synthetic growth hormone secretagogues.
Compound Specifications
| Property | Value |
|---|---|
| Compound Name | Ipamorelin |
| Classification | Synthetic growth hormone secretagogue |
| Sequence Length | 5 amino acid residues |
| Research Receptor | GHS-R1a |
| Peptide Family | Ghrelin receptor agonists |
| Source | Synthetic |
| Vial Content | 10mg |
| Research Category | Endocrine Research |
Storage and Handling
- Follow manufacturer-recommended storage conditions.
- Protect from moisture and direct light.
- Minimize temperature fluctuations.
Lyophilized Format
Ipamorelin may be supplied in lyophilized form. The actual preparation and storage requirements depend on formulation details.
Research Use Disclaimer
Ipamorelin is not FDA-approved for human therapeutic use. This research material is not intended for human or veterinary administration.
Frequently Asked Questions
What Is Ipamorelin?
A synthetic pentapeptide investigated as a GHS-R1a agonist.
Which Receptor Does It Target?
Growth hormone secretagogue receptor GHS-R1a.
Is Ipamorelin the Same as GHRP-2?
No. They are structurally different synthetic growth hormone secretagogues.
What Research Areas Involve Ipamorelin?
Growth hormone signaling, receptor pharmacology, and endocrine responses.
Is It FDA-Approved?
No.
Research Overview
Ipamorelin was developed as a synthetic growth hormone secretagogue and has been evaluated in experimental endocrine research.
GHS-R1a Research
Studies investigate receptor-mediated signaling following Ipamorelin exposure.
Growth Hormone Responses
Research has characterized endocrine responses associated with synthetic receptor agonism.
Secretagogue Selectivity
Comparative investigations have examined Ipamorelin alongside other compounds in the growth hormone secretagogue class.
Research Applications
| Research Area | In Vitro Application |
|---|---|
| GHS-R1a Research | Receptor activation assays |
| Endocrine Signaling | Hormone pathway studies |
| Peptide Pharmacology | Compound comparison assays |
References
- Raun K, Hansen BS, Johansen NL, et al. (1998). Ipamorelin, the First Selective Growth Hormone Secretagogue. European Journal of Endocrinology. Publication information.
Certificate of Analysis (COA)
Documentation should verify peptide identity, sequence, salt form, purity, and actual content. Peptide Lives.
Reviews
There are no reviews yet.